Form DRSLTR - Correspondence Related to Draft Registration Statement:
SEC Accession No. 0001640334-18-001171
Filing Date
2018-06-12
Accepted
2018-06-12 18:46:44
Documents
3

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRSLTR 32864
2 inmune_correspimg1.jpg GRAPHIC 6674
3 inmune_correspimg2.jpg GRAPHIC 1721
  Complete submission text file 0001640334-18-001171.txt   45613
Mailing Address 1224 PROSPECT STREET SUITE 150 LA JOLLA CA 92037
Business Address 1224 PROSPECT STREET SUITE 150 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

EIN.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DRSLTR
SIC: 2836 Biological Products, (No Diagnostic Substances)